The company Molecule is engaged in transforming and democratizing drug development through the use of Web3 technologies, particularly blockchain and IP-NFTs. The core activity consists of providing a platform where researchers and scientists can manage, share, and monetize their research results and intellectual property rights (IP) in the form of NFTs (Non-Fungible Tokens). The goal is to accelerate drug development, reduce costs, and improve access to medicines for all people.